Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Breakthrough status provides expedited review and closer collaboration with the FDA, ultimately enabling broader market reach and commercial adoption
Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide
With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users
Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale
Combining Singleron’s innovation in single-cell technologies with Hamilton’s expertise in laboratory automation, Tensor streamlines the single-cell sequencing process
For the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD)
Discover how VIAFLO 96 and VIAFLO 384 handheld electronic pipettes from INTEGRA Biosciences can be used to overcome key challenges associated with cell culture, including contamination, viability, and reproducibility.
Discover how thyroid stimulating immunoglobulin (TSI) testing enhances differentiation of Graves’ disease from other hyperthyroid conditions — enabling precise diagnoses and better patient care
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
New clinical insights reveal how this protein helps diagnose, monitor, and predict flare-ups in rheumatic diseases
Both REQORSA alone and in combination with LUMAKRAS demonstrated robust anti-tumor effects in Ras inhibitor resistant non-small cell lung cancer
As part of LabWeek, Dr. Umama Shahid shares her research on riboswitches and their potential to combat antimicrobial resistance
